Call for Abstract

40th World Cancer Conference, will be organized around the theme “Building bridges to combat cancer”

World Cancer 2021 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in World Cancer 2021

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Tumor Biology
  • Track 1-2Cancer Epigenetics
  • Track 1-3Oncogenes & Proto-oncogenes
  • Track 1-4Tumour Suppressor Genes
  • Track 1-5Chemo preventive Measures
  • Track 2-1CSCs and Cancer Treatment
  • Track 2-2Cancer Stem Cells
  • Track 2-3Stem Cell Transplantation
  • Track 2-4Bone Marrow Transplantation
  • Track 3-1Skin Cancer
  • Track 3-2Lung Cancer
  • Track 3-3Pancreatic Cancer
  • Track 3-4Radiation Oncology
  • Track 4-1Diagnostic Biomarkers
  • Track 4-2Predictive & Prognostic Biomarkers
  • Track 4-3Tumour Suppressors Biomarkers
  • Track 4-4Molecular Cancer Biomarkers
  • Track 5-1Clinical Trails
  • Track 5-2HPV & Hepatitis B vaccine
  • Track 5-3Therapeutic Cancer Vaccines
  • Track 5-4Oncolytic Viral Therapies
  • Track 5-5Oncoviruses
  • Track 5-6Personalised Cancer Vaccines
  • Track 7-1Pharmacokinetics and Pharmacodynamics
  • Track 7-2Clinical Pharmacology
  • Track 7-3Biochemical Pharmacology
  • Track 7-4Molecular Carcinogenesis
  • Track 7-5Cancer Drug Targets
  • Track 9-1Medical Oncology
  • Track 9-2Surgical Oncology
  • Track 9-3Paediatric Oncology
  • Track 9-4Radiation Oncology
  • Track 9-5Gynaecologic Oncology
  • Track 10-1Physiology & Cancer History
  • Track 10-2Identifying Risk Factors
  • Track 10-3Genomic & Biologic Factors
  • Track 10-4Genomic & Biologic Factors
  • Track 11-1Cancer Etiology
  • Track 11-2Cancer Etiology
  • Track 11-3Health Disparities
  • Track 11-4Genetic and molecular epidemiology
  • Track 11-5Gene-Environment Interactions
  • Track 12-1Immunotherapy
  • Track 12-2Radiation Therapy
  • Track 12-3Chemotherapy
  • Track 12-4Hormonal Therapy
  • Track 12-5Stem Cell Therapy
  • Track 13-1Antibody Therapy
  • Track 13-2Cellular Immunotherapy
  • Track 13-3Cancer Antigens & Vaccines
  • Track 13-4Clinical Cancer immunology
  • Track 13-5Cancer Immunosurveillance and Immunoediting
  • Track 13-6Host-Tumour Relation
  • Track 14-1Patient Assessment & Education
  • Track 14-2Management & Palliative Care
  • Track 14-3Assessing Physical & Emotional Status
  • Track 14-4Treatment Plans
  • Track 14-5Supportive Care
  • Track 14-6Direct Patient Care
  • Track 15-1Aromatherapy
  • Track 15-2Ayurveda
  • Track 15-3Reflexology
  • Track 15-4Anti-Cancer Agents in Medicinal Chemistry
  • Track 15-5Naturopathy
  • Track 16-1Oncogenesis
  • Track 16-2Avoiding Risk Factors
  • Track 16-3Changing Lifestyle Choices
  • Track 16-4Preclinical & Clinical Research
  • Track 16-5Early Detection Research
  • Track 16-6Immunoprevention
  • Track 16-7Avoiding Risk Factors
  • Track 16-8Oncogenesis
  • Track 16-9Cancer Surgery